CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank25
3Y CAGR-16.6%
5Y CAGR-15.8%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-16.6%/yr
vs -13.1%/yr prior
5Y CAGR
-15.8%/yr
Consistent
Acceleration
-3.5pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $151.57M | +25.7% |
| 2024 | $120.53M | -40.3% |
| 2023 | $201.79M | -22.7% |
| 2022 | $260.89M | -23.1% |
| 2021 | $339.41M | -5.4% |
| 2020 | $358.66M | +5.1% |
| 2019 | $341.28M | -25.3% |
| 2018 | $457.11M | +15.0% |
| 2017 | $397.64M | +99.7% |
| 2016 | $199.13M | - |